Cross Country Coalitions Must ‘Guarantee Confidential Pricing And Improve Access’
Industry says that if cross country-coalitions on pricing and reimbursement are to succeed, the member countries need to be similar in terms of GDP and to guarantee pricing is kept confidential.
You may also be interested in...
Cross-country collaboration on pricing and reimbursement will only work if they are based on certain overarching principles, says the European Federation of Pharmaceutical Industries and Associations.
In a BeNeLuxA first, Belgium and the Netherlands have reached an agreement with Biogen to reimburse rare disease treatment Spinraza after joint health technology assessment and pricing negotiations.
The Valletta group of southern EU states on improving access to medicines continues to expand and now includes Croatia.